Table 1.
Groups A-Fenbendazole and B-Metronidazole: dog's data (gender, age, fur length, clinical score), Giardia cysts per gram (CPG) of feces (mean, standard deviation), and efficacy (%) of the treatment at the different study days.
| Dog ID | Gender (Male/Female) | Age (months/years) | Fur length (Long/Short) | Clinical score | Giardia cysts per gram (CPG) of feces | ||||
|---|---|---|---|---|---|---|---|---|---|
| Day-5 (Pre-T) | Day 7 (T1) | Day 14 (T2) | Day 21 (T3) | Day 50 | |||||
| GROUP A (FENBENDAZOLE) | |||||||||
| F1 | M | 2 mos | L | 4 | 22,300 | 0 | 0 | 8,360 | 0 |
| F2 | F | 4 yrs | S | 3 | 15,600 | 0 | 0 | 0 | 0 |
| F3 | M | 8 mos | L | 1 | 19,200 | 21,600 | 0 | 0 | 0 |
| F4 | M | 2 yrs | S | 1 | 7,830 | 1,230 | 0 | 0 | 0 |
| F5 | F | 1 yr | S | 3 | 18,894 | 0 | 0 | 0 | 0 |
| F6 | F | 3 mos | L | 4 | 24,600 | 16,828 | 0 | 0 | 0 |
| F7 | F | 1 yr | L | 2 | 21,080 | 0 | 0 | 0 | 0 |
| F8 | M | 9 mos | S | 3 | 31,984 | 0 | 0 | 0 | 0 |
| F9 | F | 2 yrs | S | 2 | 22,824 | 0 | 0 | 0 | 12,576 |
| F10 | M | 3 yrs | L | 1 | 16,854 | 0 | 0 | 0 | 0 |
| F11 | F | 7 mos | S | 3 | 48,000 | 0 | 0 | 0 | 0 |
| F12 | M | 3 yrs | L | 1 | 2,780 | 8,400 | 0 | 0 | 0 |
| Mean CPG | 20,995.5 | 4,004.8 | 0.0 | 696.7 | 1,048.0 | ||||
| SD | 11390.1 | 7564.0 | 0.0 | 2413.3 | 3630.4 | ||||
| %Efficacy | NA | 80.9% | 100% | 97.0% | 95.0% | ||||
| GROUP B (METRONIDAZOLE) | |||||||||
| M1 | F | 4 yrs | S | 4 | 19,654 | 0 | 0 | 0 | 0 |
| M2 | F | 4 yrs | S | 3 | 11,900 | 0 | 0 | 0 | 0 |
| M3 | F | 8 mos | L | 1 | 10,900 | 0 | 0 | 0 | 0 |
| M4 | M | 2 yrs | S | 1 | 21,234 | 0 | 0 | 0 | 0 |
| M5 | F | 2 yrs | L | 2 | 10,848 | 0 | 0 | 0 | 0 |
| M6 | M | 9 mos | S | 1 | 21,280 | 0 | 0 | 0 | 6,546 |
| M7 | M | 3 yrs | S | 1 | 18,732 | 560 | 156 | 0 | 0 |
| M8 | F | 1 yr | L | 2 | 15,832 | 17,560 | 0 | 0 | 0 |
| M9 | M | 6 mos | S | 3 | 17,459 | 18,981 | 0 | 0 | 0 |
| M10 | F | 5 yrs | L | 2 | 17,178 | 17,562 | 0 | 0 | 0 |
| M11 | M | 5 mos | L | 4 | 32,178 | 10,400 | 0 | 0 | 0 |
| M12 | F | 7 mos | S | 2 | 25,765 | 0 | 1,987 | 0 | 0 |
| Mean CPG | 18,580.0 | 5,421.9 | 178.6 | 0.0 | 545.5 | ||||
| SD | 6224.6 | 8161.8 | 571.3 | 0.0 | 1889.7 | ||||
| %Efficacy | NA | 70.8% | 99.0% | 100% | 97.1% | ||||
Pre-T (before treatment); T1 (first treatment); T2 (second treatment) T3 (third treatment). Clinical score: (1) formed feces and no clinical symptoms, (2) formed feces and clinical symptoms, (3) soft stools and clinical symptoms, and (4) diarrhea and clinical symptoms.